Fgfr3 Fibroblast Growth Factor Receptor 3 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications. [1]
Fibroblast Growth Factor Receptor 3 (FGFR3) is a receptor tyrosine kinase (RTK) that plays critical roles in skeletal development, tissue maintenance, and cellular proliferation. FGFR3 belongs to the FGFR family (FGFR1-4), which binds fibroblast growth factors (FGFs) to activate downstream signaling cascades controlling cell survival, differentiation, and migration. While FGFR3 is best known for its role in bone and cartilage development—where gain-of-function mutations cause skeletal dysplasias like achondroplasia—emerging evidence links FGFR3 to neuronal function and neurodegeneration. FGFR3 signaling affects neurogenesis, oligodendrocyte development, and synaptic plasticity, with dysregulation implicated in Alzheimer's disease, Parkinson's disease, and multiple sclerosis. [2]
| Fibroblast Growth Factor Receptor 3 | |
|---|---|
| Gene Symbol | FGFR3 |
| Full Name | Fibroblast Growth Factor Receptor 3 |
| Chromosome | 4p16.3 |
| NCBI Gene ID | [2261](https://www.ncbi.nlm.nih.gov/gene/2261) |
| OMIM | 134934 |
| Ensembl ID | ENSG00000068078 |
| UniProt ID | [P22607](https://www.uniprot.org/uniprot/P22607) |
| Associated Diseases | Achondroplasia, Thanatophoric dysplasia, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis |
The FGFR3 gene spans approximately 16.5 kb on chromosome 4p16.3 and consists of 19 exons encoding a transmembrane receptor tyrosine kinase of 808 amino acids. FGFR3 follows the classic RTK architecture:
FGFR3 undergoes alternative splicing generating multiple isoforms:
FGFR3 is activated by binding of fibroblast growth factors (FGFs), leading to:
Dimerization and Autophosphorylation: FGF binding induces receptor dimerization and trans-autophosphorylation of tyrosine residues
Downstream Signaling Cascades:
In the nervous system, FGFR3 participates in:
Neurogenesis: FGF signaling through FGFR3 regulates neural stem cell proliferation and differentiation
Oligodendrocyte Development: FGFR3 is expressed in oligodendrocyte precursor cells (OPCs) and promotes:
Synaptic Plasticity: FGFR3 modulates:
Neuronal Survival: FGFR3 provides neurotrophic support through AKT-mediated anti-apoptotic signaling
FGFR3 has complex, stage-dependent roles in Alzheimer's disease:
Early Stage: FGFR3 activation may be protective:
Late Stage: FGFR3 dysregulation may contribute to pathology:
Therapeutic Potential: FGFR3 modulators are being investigated for AD:
FGFR3 involvement in PD includes:
Dopaminergic Neuroprotection: FGF signaling through FGFR3 supports:
Glial Function: FGFR3 in astrocytes and microglia:
FGFR3 plays important roles in demyelinating diseases:
Oligodendrocyte Precursor Cell (OPC) Biology:
Therapeutic Potential:
FGFR3 is expressed in:
In neurons:
In glia:
FGFR3 mutations cause several skeletal disorders:
| Disorder | Mutation | Phenotype |
|---|---|---|
| Achondroplasia | G380R (gain-of-function) | Rhizomelic dwarfism |
| Thanatophoric dysplasia | Multiple | Lethal skeletal dysplasia |
| Hypochondroplasia | N540K | Mild dwarfism |
| Crouzon syndrome | Multiple | Craniosynostosis |
FGFR3 is frequently mutated in:
While FGFR3 mutations are not causative for neurodegeneration:
| Compound | Mechanism | Status |
|---|---|---|
| BGJ398 (Infigratinib) | FGFR1-3 TKI | Phase 3 (cancer) |
| NVP-BGJ398 | FGFR3-selective | Preclinical |
| PRO-001 | FGFR3 antibody | Preclinical |
| Recombinant FGFs | FGFR3 agonists | Research |
FGF Ligand → FGFR3 → FRS2 → GRB2/SOS → RAS → RAF → MEK → ERK
↓
PI3K → AKT → mTOR
Fgfr3 Fibroblast Growth Factor Receptor 3 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Fgfr3 Fibroblast Growth Factor Receptor 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Fortress AM, et al. (2013). Fibroblast growth factor 14 and the neurodegenerative cascade. Neurobiol Learn Mem. 105:225-246. 2013. ↩︎
Sims JR, et al. (2009). FGF2/FGFR signaling in oligodendrocyte development. J Neurosci. 29(41):12899-12905. 2009. ↩︎